BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Ginkel FW, Nguyen HH, McGhee JR. Vaccines for mucosal immunity to combat emerging infectious diseases. Emerg Infect Dis. 2000;6:123-132. [PMID: 10756145 DOI: 10.3201/eid0602.000204] [Cited by in Crossref: 83] [Cited by in F6Publishing: 75] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zaman M, Abdel-aal AM, Fujita Y, Ziora ZM, Batzloff MR, Good MF, Toth I. Structure–Activity Relationship for the Development of a Self-Adjuvanting Mucosally Active Lipopeptide Vaccine against Streptococcus pyogenes. J Med Chem 2012;55:8515-23. [DOI: 10.1021/jm301074n] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
2 Alvarez N, Otero O, Camacho F, Borrero R, Tirado Y, Puig A, Aguilar A, Rivas C, Cervantes A, Falero-Díaz G, Cádiz A, Sarmiento ME, Norazmi MN, Hernández-Pando R, Acosta A. Passive administration of purified secretory IgA from human colostrum induces protection against Mycobacterium tuberculosis in a murine model of progressive pulmonary infection. BMC Immunol 2013;14 Suppl 1:S3. [PMID: 23458564 DOI: 10.1186/1471-2172-14-S1-S3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
3 Tsuji N, Suzuki K, Kasuga-Aoki H, Isobe T, Arakawa T, Matsumoto Y. Mice intranasally immunized with a recombinant 16-kilodalton antigen from roundworm Ascaris parasites are protected against larval migration of Ascaris suum. Infect Immun 2003;71:5314-23. [PMID: 12933879 DOI: 10.1128/IAI.71.9.5314-5323.2003] [Cited by in Crossref: 57] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
4 Yao X, Yuan M, Li D. Mucosal inoculation of Lactobacillus expressing hCGβ induces an anti-hCGβ antibody response in mice of different strains. Methods 2006;38:124-32. [DOI: 10.1016/j.ymeth.2005.09.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
5 Denis F, Hantz S, Alain S. [Immunity and antiviral vaccinations. Example: the respiratory mucosa]. Antibiotiques (Paris) 2007;9:130-8. [PMID: 32288532 DOI: 10.1016/S1294-5501(07)88778-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Çokçalışkan C, Özyörük F, Gürsoy RN, Alkan M, Günbeyaz M, Arca HÇ, Uzunlu E, Şenel S. Chitosan-based systems for intranasal immunization against foot-and-mouth disease. Pharmaceutical Development and Technology 2013;19:181-8. [DOI: 10.3109/10837450.2013.763263] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
7 de la Maza LM, Zhong G, Brunham RC. Update on Chlamydia trachomatis Vaccinology. Clin Vaccine Immunol 2017;24:e00543-16. [PMID: 28228394 DOI: 10.1128/CVI.00543-16] [Cited by in Crossref: 58] [Cited by in F6Publishing: 42] [Article Influence: 14.5] [Reference Citation Analysis]
8 Tutykhina IL, Logunov DY, Shcherbinin DN, Shmarov MM, Tukhvatulin AI, Naroditsky BS, Gintsburg AL. Development of adenoviral vector-based mucosal vaccine against influenza. J Mol Med (Berl) 2011;89:331-41. [PMID: 21104066 DOI: 10.1007/s00109-010-0696-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
9 Guy B. Evaluation of events occurring at mucosal surfaces: techniques used to collect and analyze mucosal secretions and cells. Clin Diagn Lab Immunol 2002;9:753-62. [PMID: 12093669 DOI: 10.1128/cdli.9.4.753-762.2002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
10 Burgess LTH, Steele MKE, Schoneboom M(BA, Grieder FB. Clinicopathologic Features of Viral Agents of Potential Use by Bioterrorists. Clinics in Laboratory Medicine 2001;21:475-94. [DOI: 10.1016/s0272-2712(18)30019-2] [Cited by in Crossref: 9] [Article Influence: 0.5] [Reference Citation Analysis]
11 Li M, Cuff CF, Pestka J. Modulation of Murine Host Response to Enteric Reovirus Infection by the Trichothecene Deoxynivalenol. Toxicological Sciences 2005;87:134-45. [DOI: 10.1093/toxsci/kfi225] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 3.2] [Reference Citation Analysis]
12 King RG, Silva-Sanchez A, Peel JN, Botta D, Dickson AM, Pinto AK, Meza-Perez S, Allie SR, Schultz MD, Liu M, Bradley JE, Qiu S, Yang G, Zhou F, Zumaquero E, Simpler TS, Mousseau B, Killian JT Jr, Dean B, Shang Q, Tipper JL, Risley CA, Harrod KS, Feng T, Lee Y, Shiberu B, Krishnan V, Peguillet I, Zhang J, Green TJ, Randall TD, Suschak JJ, Georges B, Brien JD, Lund FE, Roberts MS. Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal Challenge. Vaccines (Basel) 2021;9:881. [PMID: 34452006 DOI: 10.3390/vaccines9080881] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
13 Ferro VA, Pérez O. Adjuvant strategies required for targeting mucosal tissues. Methods 2009;49:299-300. [DOI: 10.1016/j.ymeth.2009.10.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
14 Lavelle EC, O’hagan DT. Delivery systems and adjuvants for oral vaccines. Expert Opinion on Drug Delivery 2006;3:747-62. [DOI: 10.1517/17425247.3.6.747] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 5.1] [Reference Citation Analysis]
15 Ren JM, Zou QM, Wang FK, He Q, Chen W, Zen WK. PELA microspheres loaded H. pylori lysates and their mucosal immune response. World J Gastroenterol 2002; 8(6): 1098-1102 [PMID: 12439933 DOI: 10.3748/wjg.v8.i6.1098] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
16 Fasina YO, Holt PS, Moran ET, Moore RW, Conner DE, McKee SR. Intestinal cytokine response of commercial source broiler chicks to Salmonella typhimurium infection. Poult Sci 2008;87:1335-46. [PMID: 18577613 DOI: 10.3382/ps.2007-00526] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
17 Dedieu-Engelmann L. Contagious bovine pleuropneumonia: a rationale for the development of a mucosal sub-unit vaccine. Comp Immunol Microbiol Infect Dis 2008;31:227-38. [PMID: 17706775 DOI: 10.1016/j.cimid.2007.07.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
18 Bakkari MA, Valiveti CK, Kaushik RS, Tummala H. Toll-like Receptor-4 (TLR4) Agonist-Based Intranasal Nanovaccine Delivery System for Inducing Systemic and Mucosal Immunity. Mol Pharm 2021;18:2233-41. [PMID: 34010002 DOI: 10.1021/acs.molpharmaceut.0c01256] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Cao YG, Hao Y, Wang L. A Bacillus-based Coxsackie virus A16 mucosal vaccine induces strong neutralizing antibody responses. Cent Eur J Immunol 2019;44:1-6. [PMID: 31114430 DOI: 10.5114/ceji.2019.84009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Silva AJ, Mohan A, Benitez JA. Cholera vaccine candidate 638: intranasal immunogenicity and expression of a foreign antigen from the pulmonary pathogen Coccidioides immitis. Vaccine 2003;21:4715-21. [DOI: 10.1016/s0264-410x(03)00515-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
21 Kam YW, Kien F, Roberts A, Cheung YC, Lamirande EW, Vogel L, Chu SL, Tse J, Guarner J, Zaki SR, Subbarao K, Peiris M, Nal B, Altmeyer R. Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro. Vaccine 2007;25:729-40. [PMID: 17049691 DOI: 10.1016/j.vaccine.2006.08.011] [Cited by in Crossref: 139] [Cited by in F6Publishing: 123] [Article Influence: 9.3] [Reference Citation Analysis]
22 Romero EL, Morilla MJ. Topical and mucosal liposomes for vaccine delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011;3:356-75. [PMID: 21360692 DOI: 10.1002/wnan.131] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
23 McFarland EJ, Karron RA, Muresan P, Cunningham CK, Libous J, Perlowski C, Thumar B, Gnanashanmugam D, Moye J, Schappell E, Barr E, Rexroad V, Fearn L, Spector SA, Aziz M, Cielo M, Beneri C, Wiznia A, Luongo C, Collins P, Buchholz UJ. Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children. J Infect Dis 2020;221:534-43. [PMID: 31758177 DOI: 10.1093/infdis/jiz603] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
24 Bernasconi V, Norling K, Bally M, Höök F, Lycke NY. Mucosal Vaccine Development Based on Liposome Technology. J Immunol Res 2016;2016:5482087. [PMID: 28127567 DOI: 10.1155/2016/5482087] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 6.8] [Reference Citation Analysis]
25 Nochi T, Jansen CA, Toyomizu M, van Eden W. The Well-Developed Mucosal Immune Systems of Birds and Mammals Allow for Similar Approaches of Mucosal Vaccination in Both Types of Animals. Front Nutr 2018;5:60. [PMID: 30050906 DOI: 10.3389/fnut.2018.00060] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
26 Lloyd Spencer J. Immunization via the anal mucosa and adjacent skin to protect against respiratory virus infections and allergic rhinitis: a hypothesis. Med Hypotheses 2010;74:542-6. [PMID: 19853382 DOI: 10.1016/j.mehy.2009.09.046] [Reference Citation Analysis]
27 Jiang T, Singh B, Maharjan S, Li HS, Kang SK, Bok JD, Cho CS, Choi YJ. Oral delivery of probiotic expressing M cell homing peptide conjugated BmpB vaccine encapsulated into alginate/chitosan/alginate microcapsules. Eur J Pharm Biopharm 2014;88:768-77. [PMID: 25016975 DOI: 10.1016/j.ejpb.2014.07.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
28 Annas S, Zamri-Saad M. Intranasal Vaccination Strategy to Control the COVID-19 Pandemic from a Veterinary Medicine Perspective. Animals (Basel) 2021;11:1876. [PMID: 34202429 DOI: 10.3390/ani11071876] [Reference Citation Analysis]
29 Lu D, Hickey AJ. Pulmonary vaccine delivery. Expert Review of Vaccines 2014;6:213-26. [DOI: 10.1586/14760584.6.2.213] [Cited by in Crossref: 93] [Cited by in F6Publishing: 82] [Article Influence: 13.3] [Reference Citation Analysis]
30 Liu YF, Guo QH, Chen L, Zhao J, Chang HT, Wang XW, Yang X, Wang CQ. Induction of mucosal immunity by intranasal immunization with recombinant adenovirus expressing major epitopes of Porcine circovirus-2 capsid protein. Vet Immunol Immunopathol 2013;154:48-53. [PMID: 23618367 DOI: 10.1016/j.vetimm.2013.03.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
31 Henderson A, Propst K, Kedl R, Dow S. Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity. Vaccine 2011;29:5304-12. [PMID: 21600950 DOI: 10.1016/j.vaccine.2011.05.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
32 Ferro VA, Carter KC. Mucosal immunisation: Successful approaches to targeting different tissues. Methods 2006;38:61-4. [DOI: 10.1016/j.ymeth.2005.11.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
33 Dunn LA, Upcroft JA, Fowler EV, Matthews BS, Upcroft P. Orally administered Giardia duodenalis extracts enhance an antigen-specific antibody response. Infect Immun 2001;69:6503-10. [PMID: 11553595 DOI: 10.1128/IAI.69.10.6503-6510.2001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
34 Lahiri A, Sharif S, Mallick AI. Intragastric delivery of recombinant Lactococcus lactis displaying ectodomain of influenza matrix protein 2 (M2e) and neuraminidase (NA) induced focused mucosal and systemic immune responses in chickens. Mol Immunol 2019;114:497-512. [PMID: 31518854 DOI: 10.1016/j.molimm.2019.08.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
35 Ryan EJ, Daly LM, Mills KH. Immunomodulators and delivery systems for vaccination by mucosal routes. Trends in Biotechnology 2001;19:293-304. [DOI: 10.1016/s0167-7799(01)01670-5] [Cited by in Crossref: 110] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
36 Lee CH, Hajishengallis G, Connell TD. Dendritic Cell-Mediated Mechanisms Triggered by LT-IIa-B5, a Mucosal Adjuvant Derived from a Type II Heat-Labile Enterotoxin of Escherichia coli. J Microbiol Biotechnol 2017;27:709-17. [PMID: 28144014 DOI: 10.4014/jmb.1611.11072] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
37 Moon JJ, Huang B, Irvine DJ. Engineering nano- and microparticles to tune immunity. Adv Mater 2012;24:3724-46. [PMID: 22641380 DOI: 10.1002/adma.201200446] [Cited by in Crossref: 269] [Cited by in F6Publishing: 268] [Article Influence: 29.9] [Reference Citation Analysis]
38 Ge JW, Liu DQ, Li YJ. Construction of recombinant lactobacilli expressing the core neutralizing epitope (COE) of porcine epidemic diarrhea virus and a fusion protein consisting of COE and Escherichia coli heat-labile enterotoxin B, and comparison of the immune responses by orogastric immunization. Can J Microbiol 2012;58:1258-67. [PMID: 23145823 DOI: 10.1139/w2012-098] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
39 Ibe MI, Odimegwu DC, Onuigbo EB. Alginate-coated chitosan microparticles encapsulating an oral plasmid-cured live Salmonella enterica serovar Gallinarum vaccine cause a higher expression of interferon-gamma in chickens compared to the parenteral live vaccine. Avian Pathol 2019;48:423-8. [PMID: 31081347 DOI: 10.1080/03079457.2019.1616673] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
40 Ruckdeschel EA, Brauer AL, Johnson A, Murphy TF. Characterization of proteins Msp22 and Msp75 as vaccine antigens of Moraxella catarrhalis. Vaccine 2009;27:7065-72. [PMID: 19786139 DOI: 10.1016/j.vaccine.2009.09.062] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
41 Ogra PL, Faden H, Welliver RC. Vaccination strategies for mucosal immune responses. Clin Microbiol Rev 2001;14:430-45. [PMID: 11292646 DOI: 10.1128/CMR.14.2.430-445.2001] [Cited by in Crossref: 277] [Cited by in F6Publishing: 110] [Article Influence: 13.9] [Reference Citation Analysis]
42 Sabirov A, Metzger DW. Mouse models for the study of mucosal vaccination against otitis media. Vaccine 2008;26:1501-24. [PMID: 18295938 DOI: 10.1016/j.vaccine.2008.01.029] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
43 Singh B, Maharjan S, Jiang T, Kang SK, Choi YJ, Cho CS. Combinatorial Approach of Antigen Delivery Using M Cell-Homing Peptide and Mucoadhesive Vehicle to Enhance the Efficacy of Oral Vaccine. Mol Pharm 2015;12:3816-28. [PMID: 26394158 DOI: 10.1021/acs.molpharmaceut.5b00265] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
44 Spinner JL, Oberoi HS, Yorgensen YM, Poirier DS, Burkhart DJ, Plante M, Evans JT. Methylglycol chitosan and a synthetic TLR4 agonist enhance immune responses to influenza vaccine administered sublingually. Vaccine 2015;33:5845-53. [PMID: 26392012 DOI: 10.1016/j.vaccine.2015.08.086] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
45 Lin YF, Deng MC, Tseng LP, Jiang PR, Jan TR, Hsieh FI, Liu DZ. Adjuvant effect of liposome in chicken result from induction of nitric oxide. Biomed Mater 2011;6:015011. [PMID: 21239850 DOI: 10.1088/1748-6041/6/1/015011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
46 Azevedo MS, Yuan L, Pouly S, Gonzales AM, Jeong KI, Nguyen TV, Saif LJ. Cytokine responses in gnotobiotic pigs after infection with virulent or attenuated human rotavirus. J Virol. 2006;80:372-382. [PMID: 16352562 DOI: 10.1128/jvi.80.1.372-382.2006] [Cited by in Crossref: 84] [Cited by in F6Publishing: 51] [Article Influence: 6.0] [Reference Citation Analysis]
47 Wang T, Wei F, Liu J. Emerging Role of Mucosal Vaccine in Preventing Infection with Avian Influenza A Viruses. Viruses 2020;12:E862. [PMID: 32784697 DOI: 10.3390/v12080862] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
48 Chang HG, Glass RI, Smith PF, Cicirello HG, Holman RC, Morse DL. Disease burden and risk factors for hospitalizations associated with rotavirus infection among children in New York State, 1989 through 2000. Pediatr Infect Dis J 2003;22:808-14. [PMID: 14506373 DOI: 10.1097/01.inf.0000086404.31634.04] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
49 Chadwick S, Kriegel C, Amiji M. Delivery strategies to enhance mucosal vaccination. Expert Opinion on Biological Therapy 2009;9:427-40. [DOI: 10.1517/14712590902849224] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
50 McNeela EA, Mills KH. Manipulating the immune system: humoral versus cell-mediated immunity. Adv Drug Deliv Rev 2001;51:43-54. [PMID: 11516778 DOI: 10.1016/s0169-409x(01)00169-7] [Cited by in Crossref: 63] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
51 Lavelle EC, Leavy O, Mills KHG. Modified Bacterial Toxins. In: Hackett CJ, Harn DA, editors. Vaccine Adjuvants. Totowa: Humana Press; 2006. pp. 111-53. [DOI: 10.1007/978-1-59259-970-7_7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
52 Farris CM, Morrison RP. Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model. Infect Immun 2011;79:986-96. [PMID: 21078844 DOI: 10.1128/IAI.00881-10] [Cited by in Crossref: 86] [Cited by in F6Publishing: 61] [Article Influence: 7.8] [Reference Citation Analysis]
53 Liu D, Wang X, Ge J, Liu S, Li Y. Comparison of the immune responses induced by oral immunization of mice with Lactobacillus casei-expressing porcine parvovirus VP2 and VP2 fused to Escherichia coli heat-labile enterotoxin B subunit protein. Comp Immunol Microbiol Infect Dis. 2011;34:73-81. [PMID: 20226529 DOI: 10.1016/j.cimid.2010.02.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
54 Hanniffy S, Wiedermann U, Repa A, Mercenier A, Daniel C, Fioramonti J, Tlaskolova H, Kozakova H, Israelsen H, Madsen S. Potential and opportunities for use of recombinant lactic acid bacteria in human health. Adv Appl Microbiol. 2004;56:1-64. [PMID: 15566975 DOI: 10.1016/s0065-2164(04)56001-x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
55 O'Keefe SJ, Sharma S. Nutrition support in severe acute pancreatitis. Gastroenterol Clin North Am. 2007;36:297-312, viii. [PMID: 17533080 DOI: 10.1016/j.gtc.2007.03.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
56 Awram P, Gardner RC, Forster RL, Bellamy AR. The potential of plant viral vectors and transgenic plants for subunit vaccine production. Adv Virus Res 2002;58:81-124. [PMID: 12205784 DOI: 10.1016/s0065-3527(02)58003-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
57 Gallorini S, Taccone M, Bonci A, Nardelli F, Casini D, Bonificio A, Kommareddy S, Bertholet S, O'Hagan DT, Baudner BC. Sublingual immunization with a subunit influenza vaccine elicits comparable systemic immune response as intramuscular immunization, but also induces local IgA and TH17 responses. Vaccine 2014;32:2382-8. [PMID: 24434044 DOI: 10.1016/j.vaccine.2013.12.043] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
58 Bailey M, Haverson K, Miller B, Jones P, Sola I, Enjuanes L, Stokes CR. Effects of infection with transmissible gastroenteritis virus on concomitant immune responses to dietary and injected antigens. Clin Diagn Lab Immunol 2004;11:337-43. [PMID: 15013985 DOI: 10.1128/cdli.11.2.337-343.2004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
59 Tiboni M, Casettari L, Illum L. Nasal vaccination against SARS-CoV-2: Synergistic or alternative to intramuscular vaccines? Int J Pharm 2021;603:120686. [PMID: 33964339 DOI: 10.1016/j.ijpharm.2021.120686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
60 Velasquez LS, Shira S, Berta AN, Kilbourne J, Medi BM, Tizard I, Ni Y, Arntzen CJ, Herbst-Kralovetz MM. Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine. Vaccine 2011;29:5221-31. [PMID: 21640778 DOI: 10.1016/j.vaccine.2011.05.027] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 6.6] [Reference Citation Analysis]
61 Chadwick S, Kriegel C, Amiji M. Nanotechnology solutions for mucosal immunization. Advanced Drug Delivery Reviews 2010;62:394-407. [DOI: 10.1016/j.addr.2009.11.012] [Cited by in Crossref: 141] [Cited by in F6Publishing: 123] [Article Influence: 12.8] [Reference Citation Analysis]
62 Wu HS, Hsieh YC, Su IJ, Lin TH, Chiu SC, Hsu YF, Lin JH, Wang MC, Chen JY, Hsiao PW, Chang GD, Wang AH, Ting HW, Chou CM, Huang CJ. Early detection of antibodies against various structural proteins of the SARS-associated coronavirus in SARS patients. J Biomed Sci 2004;11:117-26. [PMID: 14730215 DOI: 10.1007/BF02256554] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
63 Havenith CE, Seegers JF, Pouwels PH. Gut-associated lactobacilli for oral immunisation. Food Research International 2002;35:151-63. [DOI: 10.1016/s0963-9969(01)00177-6] [Cited by in Crossref: 15] [Article Influence: 0.8] [Reference Citation Analysis]
64 Duc LH, Cutting SM. Bacterial spores as heat stable vaccine vehicles. Expert Opinion on Biological Therapy 2005;3:1263-70. [DOI: 10.1517/14712598.3.8.1263] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
65 Denis F, Alain S, Hantz S, Lagrange P. [Antiviral vaccination and respiratory mucosal immunity: still disappointing results from a seductive idea]. Presse Med 2005;34:1245-53. [PMID: 16230967 DOI: 10.1016/s0755-4982(05)84165-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
66 di Valserra MDB, Zanasi A, Ragusa S, Glück R, Herzog C. An open-label comparison of the immunogenicity and tolerability of intranasal and intramuscular formulations of virosomal influenza vaccine in healthy adults. Clinical Therapeutics 2002;24:100-11. [DOI: 10.1016/s0149-2918(02)85008-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
67 Miller DS, Parsons AM, Bresland J, Herde P, Pham DM, Tan A, Hsu HY, Prestidge CA, Kuchel T, Begg R, Aziz SM, Butler RN. A simple and inexpensive enteric-coated capsule for delivery of acid-labile macromolecules to the small intestine. J Zhejiang Univ Sci B 2015;16:586-92. [PMID: 26160716 DOI: 10.1631/jzus.B1400290] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
68 Günbeyaz M, Faraji A, Özkul A, Puralı N, Şenel S. Chitosan based delivery systems for mucosal immunization against bovine herpesvirus 1 (BHV-1). European Journal of Pharmaceutical Sciences 2010;41:531-45. [DOI: 10.1016/j.ejps.2010.08.011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
69 Stoycheva M, Murdjeva M. Correlation between Serum Levels of Interleukin-1β, Interleukin- 1RA, Interleukin-6, Interleukin-10, Interleukin 12, Tumor Necrosis Factor-α and Interferon-γ with some Clinical and Laboratory Parameters in Patients with Salmonellosis. Biotechnology & Biotechnological Equipment 2014;19:143-6. [DOI: 10.1080/13102818.2005.10817170] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
70 Pantazica AM, Cucos LM, Stavaru C, Clarke JL, Branza-Nichita N. Challenges and Prospects of Plant-Derived Oral Vaccines against Hepatitis B and C Viruses. Plants (Basel) 2021;10:2037. [PMID: 34685844 DOI: 10.3390/plants10102037] [Reference Citation Analysis]
71 Yusuf H, Kett V. Current prospects and future challenges for nasal vaccine delivery. Hum Vaccin Immunother 2017;13:34-45. [PMID: 27936348 DOI: 10.1080/21645515.2016.1239668] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 9.8] [Reference Citation Analysis]
72 Kunkel EJ, Kim CH, Lazarus NH, Vierra MA, Soler D, Bowman EP, Butcher EC. CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells. J Clin Invest 2003;111:1001-10. [PMID: 12671049 DOI: 10.1172/JCI17244] [Cited by in Crossref: 208] [Cited by in F6Publishing: 96] [Article Influence: 11.6] [Reference Citation Analysis]
73 Morrill JC, Peters CJ. Mucosal immunization of rhesus macaques with Rift Valley Fever MP-12 vaccine. J Infect Dis 2011;204:617-25. [PMID: 21791664 DOI: 10.1093/infdis/jir354] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
74 Patterson LJ, Robert-Guroff M. Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development. Expert Opin Biol Ther 2008;8:1347-63. [PMID: 18694354 DOI: 10.1517/14712598.8.9.1347] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
75 Munang'andu HM, Mutoloki S, Evensen Ø. An Overview of Challenges Limiting the Design of Protective Mucosal Vaccines for Finfish. Front Immunol 2015;6:542. [PMID: 26557121 DOI: 10.3389/fimmu.2015.00542] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
76 King RG, Silva-Sanchez A, Peel JN, Botta D, Meza-Perez S, Allie R, Schultz MD, Liu M, Bradley JE, Qiu S, Yang G, Zhou F, Zumaquero E, Simpler TS, Mousseau B, Killian JT, Dean B, Shang Q, Tipper JL, Risley C, Harrod KS, Feng R, Lee Y, Shiberu B, Krishnan V, Peguillet I, Zhang J, Green T, Randall TD, Georges B, Lund FE, Roberts S. Single-dose intranasal administration of AdCOVID elicits systemic and mucosal immunity against SARS-CoV-2 in mice. bioRxiv 2020:2020. [PMID: 33052351 DOI: 10.1101/2020.10.10.331348] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 10.0] [Reference Citation Analysis]